AMF Tjanstepension AB Buys 7,233 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

AMF Tjanstepension AB raised its stake in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 26.7% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 34,341 shares of the biotechnology company's stock after purchasing an additional 7,233 shares during the quarter. AMF Tjanstepension AB's holdings in Axon Enterprise were worth $10,745,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of AXON. ICA Group Wealth Management LLC bought a new position in Axon Enterprise in the fourth quarter valued at approximately $26,000. BKM Wealth Management LLC bought a new position in shares of Axon Enterprise during the 4th quarter worth approximately $32,000. First PREMIER Bank acquired a new stake in Axon Enterprise during the 1st quarter worth approximately $33,000. Key Financial Inc lifted its holdings in Axon Enterprise by 367.6% during the 4th quarter. Key Financial Inc now owns 159 shares of the biotechnology company's stock worth $41,000 after purchasing an additional 125 shares during the last quarter. Finally, Lindbrook Capital LLC lifted its holdings in Axon Enterprise by 43.3% during the 4th quarter. Lindbrook Capital LLC now owns 172 shares of the biotechnology company's stock worth $44,000 after purchasing an additional 52 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors.

Axon Enterprise Trading Down 1.4 %

Shares of NASDAQ:AXON traded down $4.11 during midday trading on Friday, reaching $294.24. The company's stock had a trading volume of 1,083,370 shares, compared to its average volume of 445,254. The firm has a market capitalization of $22.21 billion, a price-to-earnings ratio of 86.04 and a beta of 0.91. The company has a debt-to-equity ratio of 0.37, a quick ratio of 2.55 and a current ratio of 2.91. The firm has a 50 day moving average price of $295.25 and a two-hundred day moving average price of $285.00. Axon Enterprise, Inc. has a fifty-two week low of $175.37 and a fifty-two week high of $329.87.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its quarterly earnings data on Friday, May 10th. The biotechnology company reported $1.15 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.95 by $0.20. Axon Enterprise had a return on equity of 11.71% and a net margin of 15.60%. The company had revenue of $460.74 million for the quarter, compared to the consensus estimate of $441.57 million. During the same period in the previous year, the business earned $0.51 EPS. The firm's revenue was up 34.3% compared to the same quarter last year. As a group, analysts forecast that Axon Enterprise, Inc. will post 2.35 earnings per share for the current year.

Analyst Ratings Changes

Several research firms recently weighed in on AXON. JMP Securities reissued a "market outperform" rating and set a $375.00 price target on shares of Axon Enterprise in a report on Tuesday, May 7th. Morgan Stanley lifted their price target on Axon Enterprise from $285.00 to $310.00 and gave the stock an "equal weight" rating in a report on Friday, April 26th. William Blair reissued an "outperform" rating on shares of Axon Enterprise in a report on Wednesday, April 24th. JPMorgan Chase & Co. lifted their price target on Axon Enterprise from $330.00 to $365.00 and gave the stock an "overweight" rating in a report on Thursday, April 11th. Finally, Needham & Company LLC reaffirmed a "buy" rating and issued a $400.00 price objective on shares of Axon Enterprise in a report on Tuesday, May 7th. Two research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $335.27.

Insider Activity at Axon Enterprise

In related news, President Joshua Isner sold 44,000 shares of the business's stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $309.96, for a total value of $13,638,240.00. Following the completion of the sale, the president now directly owns 275,843 shares of the company's stock, valued at approximately $85,500,296.28. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other Axon Enterprise news, Director Jeri Williams sold 308 shares of the business's stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $310.07, for a total transaction of $95,501.56. Following the completion of the sale, the director now directly owns 1,607 shares of the company's stock, valued at approximately $498,282.49. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, President Joshua Isner sold 44,000 shares of the business's stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $309.96, for a total value of $13,638,240.00. Following the sale, the president now directly owns 275,843 shares of the company's stock, valued at $85,500,296.28. The disclosure for this sale can be found here. Insiders sold 89,447 shares of company stock valued at $27,684,677 in the last three months. Corporate insiders own 6.10% of the company's stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.